ACC releases new appropriate use criteria for coronary revascularisation

238

The American College of Cardiology (ACC), along with several partnering organisations, has released updated appropriate use criteria for performing coronary revascularisation in patients with acute coronary syndromes. The criteria have been published by the Journal of the American College of Cardiology.

The appropriate use criteria document includes clinical scenarios developed to mimic patient presentations that may be encountered in everyday practice and information on symptom status, presence of clinical instability or ongoing ischemic symptoms, prior reperfusion therapy, risk level as assessed by noninvasive testing, fractional flow reserve testing, and coronary anatomy.

“This update provides a reassessment of clinical scenarios that the writing group felt to be affected by significant changes in the medical literature or gaps from prior criteria,” says Manesh R Patel, chief of the division of cardiology and co-director of the Duke Heart Center at Duke University (Durham, USA) and chair of the writing committee for the document. “The primary objective of the appropriate use criteria is to provide a framework for the assessment of practice patterns that will hopefully improve physician decision making and ultimately lead to better patient outcomes.”

The clinical scenarios are scored to indicate whether revascularisation is appropriate, may be appropriate or is rarely appropriate for the clinical scenario presented.

The document can be used as a clinical tool to assist clinicians in evaluating therapies and can help to better inform patients about their treatment options.

The writing committee stresses that the criteria should be used as an overall guide, and physicians should evaluate each case on an individual basis.

These appropriate use criteria are a product of a partnership between the ACC, the American Association for Thoracic Surgery, the American Heart Association, American Society of Echocardiography, the American Society of Nuclear Cardiology, the Society for Cardiovascular Angiography and Interventions, the Society of Cardiovascular Computed Tomography and the Society of Thoracic Surgeons. The document is part one of a two-part revision for coronary revascularisation. The updated appropriate use criteria for coronary revascularisation in patients with stable ischaemic heart disease are forthcoming.